EuGeni, page-2252

All I can say I've been banging on about this specifically for near 2 years. However I do accept what I post may be received in a number of different ways especially if it implies I am critical about how ADO go about doing 'business'.

My views and opinions have not changed even with new mgt. It may take many more months about how effective they are in promoting ADO into a credible disruptor in the battery space.

My next critique will be the 12 month result to see how much 'extra' they extracted from the updated Ellume supply contract, if they still can't do better than last years result, well it wouldn't have amounted for too much, not what we were told a few months ago.

	Column 1	Column 2	Column 3	Column 4	Column 5	Column 6
0		Consolidated statement of cash flows	Period Ending June 2020	Period Ending June 2021	Period Ending March 2022	Period Ending June 2022
1		Quarterlies Dates - 31/01 - 21/04 - 28/10 - 30/07	Year to date (12 months) $A’000	Year to date (12 months) $A’000	Year to date (9 months) $A’000	Year to date (12 months) $A’000
2
3	1	Cash flows from operating activities
4
5	1.1	Receipts from customers	279	889	566
6	1.2	Payments for
7		(a) research and development	-593	-1,994	-1,733
8		(b) product manufacturing and operating costs		-722	-470
9		(c) advertising and marketing	-265	-342
10		(d) leased assets	-322	-299	-317
11		(e) staff costs	-2,240	-2,916	-3,823
12		(f) administration and corporate costs	-576	-653	-940
13	1.3	Dividends received (see note 3)
14	1.4	Interest received	6	5	2
15	1.5	Interest and other costs of finance paid
16	1.6	Income taxes paid
17	1.7	Government grants and tax incentives	966	1,401	1,965
18	1.8	Other (ATO cash boost)		100
19	1.9	Net cash from / (used in) operating activities	-2,745	-4,531	-5,156